Guidelines For Drug Treatment Of Epilepsy: A Critical Review

This article critically reviews the role of evidence-based medicine and its guidelines, from their logistic preparation to their interpretation. The strengths and weaknesses of the methodological points are presented, as well the reasons for the extreme popularity of the guidelines in developed countries. The review discusses the main foundations of the most cited guidelines and some recent large studies. Some of the final conclusions are that clinical experience is always an important factor to consider, even in the face of solid evidence, to achieve the best possible management of any particular patient.663 A591599French, J.A., Kanner, A.M., Bautista, J., Efficacy and tolerability of the new antiepileptic drugs: I: Treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy and the American Epilepsy Society (2004) Neurology, 62, pp. 1252-1260French, J.A., Kanner, A.M., Bautista, J., Efficacy and tolerability of the new antiepileptic drugs: II: Treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2004) Neurology, 62, pp. 1261-1273Glauser, T., Ben-Menachen, E., Bourgeois, B., ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes (2006) Epilepsia, 47, pp. 1094-1120Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-1015Marson, A.G., Al-Kharusi, A.M., Alwaidh, M., The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: An unblinded randomised controlled trial (2007) Lancet, 369, pp. 1016-1026Sackett, D.L., Strauss, S.E., Richardson, W.S., Evidence Based Medicine (2000) How to Practice and Teach EBM, , Edinburgh: Churchill LivingstoneGlasziou, P., Del Mar, C., Salisbury, J., (2003) Evidence-based Medicine Workbook, , Finding and applying the best research evidence to improve patient care. London: BMJ Books, BMJ Publishing GroupDans, A.L., Dans, L.F., The need and means for evidence-based medicine in developing countries (2000) ACP J Club, 133, pp. 11-12Liberati, A., Moja, L.P., Moschetti, I., Evidence-based medicine: Its contributions in the way we search, appraise and apply scientific information to patient care (2007) Evidence-based Neurology. Management of Neurological Disorders, pp. 3-10. , Candelise L, Hughes R, Liberati A, Uitdehaag BM, Warlow C Eds, Blackwell Publishing, BMJ BooksMayer, D., (2004) Essential Evidence-based Medicine, , Cambridge: University PressDefinition of key terms (1990) Clinical practice guidelines: Directions for a new program, pp. 33-51. , Institute of Medicine, Field MJ, Lohr KN, Eds, Washington, DC: National Academy PressCavalcante, A.B., Silva, E., Prática da medicina baseada em evidências: Acessando com eficiência bases de dados eletrônicas. Einstein (2007) Educ Contin Saúde, 5 (4 PART 2), pp. 109-111Hirtz, D., Ashwal, S., Berg, A., Practice parameter: Evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society (2000) Neurology, 55, pp. 616-623Hirtz, D., Berg, A., Bettis, D., Practice parameter: Treatment of the child with a first unprovoked seizure: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society (2003) Neurology, 60, pp. 166-175Engel Jr, J., Wiebe, S., French, J., Practice parameter: Temporal lobe and localized neocortical resections for epilepsy. Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons (2003) Neurology, 60, pp. 538-547Chen, D.K., So, Y.T., Fisher, R.S., Use of serum prolactin in diagnosing epileptic seizures. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (2005) Neurology, 65, pp. 668-675Harden, C.L., Huff, J.S., Schwartz, T.H., Neuroimaging in the emergency patient presenting with seizure (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (2007) Neurology, 69, pp. 1772-1780Krumholz, D., Wiebe, S., Gronseth, G., Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2007) Neurology, 69, pp. 1996-2007National Institute for Clinical Excellence. Newer drugs for epilepsy in adults. www.nice.org.uk/Docret.asp?d=110081 - accessed May 5, 2008) National Institute for Clinical Excellence. Newer drugs for epilepsy in children. www.nice.org.uk/Docret.asp?d=113359 - accessed May 5, 2008Handbook for the preparation of explicit evidence-based clinical practice guidelines, , www.nzgg.org.nz/download/files/nzgg_guideline_handbook.pdf, New Zealand Guidelines Group, accessed May 5,2008Warlow, C., What to do when there is no evidence (2007) Evidence-based Neurology. Management of Neurological Disorders, pp. 11-14. , Candelise L, Hughes R, Liberati A, Uitdehaag BM, Warlow C Eds, Blackwell Publishing, BMJ BooksDiagnosis and management of epilepsy in adults. Guideline no. 70, Publication, , www.sign.ac.uk/guidelines/fulltext/70/index.html, April 2003Chadwick, D., Marson, T., Choosing a first drug treatment for epilepsy after SANAD: Randomized controlled trials, systematic reviews, guidelines and treating patients (2007) Epilepsia, 48, pp. 1259-1263Panayiotopoulos, C.P., Evidence-based epileptology, randomized controlled trials, and SANAD: A critical clinical view (2007) Epilepsia, 48, pp. 1268-1274Brodie, M.J., Perruca, E., Ryvlin, P., Ben-Menachem, E., Meencke, H.J., Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy (2007) Neurology, 68, pp. 402-40